Roche to reshuffle management and board
Roche’s leadership will look quite different next year, when both the chief executive and chairman positions will have been filled by different people, the firm announced Thursday.
by christopher due karlsson, translated by daniel pedersen
Swiss pharmaceutical firm Roche is facing a significant restructuring to its leadership at its annual general meeting next year.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Roche awarded priority review status for Genmab drug rival
For subscribers
.jpg)
.jpg&w=384&q=75)
